JP2010523598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010523598A5 JP2010523598A5 JP2010502350A JP2010502350A JP2010523598A5 JP 2010523598 A5 JP2010523598 A5 JP 2010523598A5 JP 2010502350 A JP2010502350 A JP 2010502350A JP 2010502350 A JP2010502350 A JP 2010502350A JP 2010523598 A5 JP2010523598 A5 JP 2010523598A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- terminus
- modified
- peptide chain
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 55
- 150000001875 compounds Chemical class 0.000 claims 25
- 230000002401 inhibitory effect Effects 0.000 claims 14
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 125000003368 amide group Chemical group 0.000 claims 8
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 5
- 125000002252 acyl group Chemical group 0.000 claims 4
- 102000003923 Protein Kinase C Human genes 0.000 claims 3
- 108090000315 Protein Kinase C Proteins 0.000 claims 3
- RAVVEEJGALCVIN-AGVBWZICSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-5-(diamino Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RAVVEEJGALCVIN-AGVBWZICSA-N 0.000 claims 1
- 108700031308 Antennapedia Homeodomain Proteins 0.000 claims 1
- 108700000788 Human immunodeficiency virus 1 tat peptide (47-57) Proteins 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 claims 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical group [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 claims 1
- 230000014725 late viral mRNA transcription Effects 0.000 claims 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 claims 1
- 108010011110 polyarginine Proteins 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91058807P | 2007-04-06 | 2007-04-06 | |
| PCT/US2008/059591 WO2008124698A2 (en) | 2007-04-06 | 2008-04-07 | Methods of use of gamma inhibitor compounds for the attenuation of pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010523598A JP2010523598A (ja) | 2010-07-15 |
| JP2010523598A5 true JP2010523598A5 (enExample) | 2012-07-12 |
Family
ID=39831558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010502350A Pending JP2010523598A (ja) | 2007-04-06 | 2008-04-07 | 痛みの軽減のためのガンマ阻害剤化合物の使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090062178A1 (enExample) |
| EP (1) | EP2144615A4 (enExample) |
| JP (1) | JP2010523598A (enExample) |
| CN (1) | CN101969960A (enExample) |
| AU (1) | AU2008237138B2 (enExample) |
| CA (1) | CA2693256A1 (enExample) |
| MX (1) | MX2009010757A (enExample) |
| WO (1) | WO2008124698A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2124987A4 (en) * | 2007-01-19 | 2012-05-02 | Kai Pharmaceuticals Inc | METHOD OF USE OF EPSILON HEMMER COMPOUNDS FOR PAIN LIFTING |
| AU2009288088B2 (en) * | 2008-09-03 | 2014-12-04 | Nono Inc. | Agents and methods for treatment of pain |
| US11208446B2 (en) | 2016-11-01 | 2021-12-28 | Memorial Sloan Kettering Cancer Cenier | Agents and methods for treating CBP-dependent cancers |
| IT201800009384A1 (it) * | 2018-10-11 | 2020-04-11 | Cosmo Srl | Peptide for cosmetic application |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| US6376467B1 (en) * | 1998-10-09 | 2002-04-23 | The Regents Of The University Of California | Use of inhibitors of protein kinase C epsilon to treat pain |
| MXPA02007674A (es) * | 2000-02-08 | 2002-12-13 | Amgen Inc | Moleculas similares a interlucina-17 y uso de las mismas. |
| US7507711B2 (en) * | 2002-04-22 | 2009-03-24 | The Board Of Trustees Of The Leland Stanford Junior University | Peptide inhibitors of protein kinase C |
| US6933275B2 (en) * | 2002-05-01 | 2005-08-23 | The Board Of Trustees Of The Leland Stanford Junior University | Protein kinase C peptides for use in withdrawal |
| US7265092B2 (en) * | 2004-09-30 | 2007-09-04 | Kai Pharmaceuticals, Inc. | Pharmaceutical formulation |
| EP2124987A4 (en) * | 2007-01-19 | 2012-05-02 | Kai Pharmaceuticals Inc | METHOD OF USE OF EPSILON HEMMER COMPOUNDS FOR PAIN LIFTING |
-
2008
- 2008-04-07 US US12/099,074 patent/US20090062178A1/en not_active Abandoned
- 2008-04-07 MX MX2009010757A patent/MX2009010757A/es not_active Application Discontinuation
- 2008-04-07 AU AU2008237138A patent/AU2008237138B2/en not_active Expired - Fee Related
- 2008-04-07 CN CN2008800188672A patent/CN101969960A/zh active Pending
- 2008-04-07 WO PCT/US2008/059591 patent/WO2008124698A2/en not_active Ceased
- 2008-04-07 JP JP2010502350A patent/JP2010523598A/ja active Pending
- 2008-04-07 CA CA2693256A patent/CA2693256A1/en not_active Abandoned
- 2008-04-07 EP EP08745252A patent/EP2144615A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014224126A5 (enExample) | ||
| JP2010534684A5 (enExample) | ||
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2010065037A5 (enExample) | ||
| NZ704192A (en) | Cell-penetrating peptides and uses therof | |
| MX2009000656A (es) | Acidos nucleicos que se fijan a sdf-i. | |
| IN2014CN02050A (enExample) | ||
| NZ591612A (en) | Prevention, treatment and diagnosis of p.gingivalis infection with peptides | |
| JP2013520426A5 (enExample) | ||
| NZ609216A (en) | Anticancer fusion protein | |
| WO2008133164A1 (ja) | アミノ末端1箇所で配向制御固定化された固定化タンパク質 | |
| ATE482978T1 (de) | Mimetische cd4-peptide und ihre verwendungen | |
| MX2010003109A (es) | Acidos nucleicos de enlace c5a. | |
| JP2010523598A5 (enExample) | ||
| MX337801B (es) | Acidos nucleicos que se enlazan on mcp-1. | |
| WO2009047992A1 (ja) | Udp-グルクロン酸転移酵素およびそれをコードするポリヌクレオチド | |
| EA200901441A1 (ru) | Новые молекулы антител и нуклеиновых кислот, связывающиеся с грибным белком теплового шока hsp90 | |
| JP2010265269A5 (enExample) | ||
| WO2008113536A8 (en) | Neurotrophic peptides | |
| WO2008066816A3 (en) | Derivatization or ligaton of peptides | |
| ATE453664T1 (de) | Hausstaubmilbenallergen | |
| JP2010512326A5 (enExample) | ||
| JP2015119721A5 (enExample) | ||
| WO2010057242A3 (de) | Vakzin | |
| JP2006503088A5 (enExample) |